DGX · CUSIP 74834L100
Quest Diagnostics Inc.
Reported by 3 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-10-26.
- Managers holding
- 3
- Average portfolio weight
- 0.5%
- Combined reported value
- $333.6M
- Research group
- 79
3 of the 79 superinvestors Shameless Cloning tracks reported Quest Diagnostics Inc. (DGX) in their Q2 2026 13F filings, worth $333.6M combined, at an average 0.5% of their portfolios. The largest positions by portfolio weight belong to Christopher Davis (1.4%), Steven Check (0.0%), First Eagle Investment Management (0.0%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Christopher DavisDavis Selected Advisers | 1.4% | $329.8M |
| Steven CheckCHECK CAPITAL MANAGEMENT INC/CA | 0.0% | $551K |
| First Eagle Investment ManagementFirst Eagle Investment Management, LLC | 0.0% | $3.2M |